Please wait.'

Page is loading'


Home  > Markets & companies  > Raw materials market  > Evonik joint venture expands capacity for...

Saturday, 21 September 2019
pdf
Markets & companies, Raw materials market

Evonik joint venture expands capacity for TAA derivatives in China

Wednesday, 4 April 2018

Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd. (ETL) has increased its production capacity for triacetonamine (TAA) derivatives in Liaoyang by 50 percent.

The production capacity for triacetonamine (TAA) derivatives in Liaoyang rises by 50 percent. Source: Evonik.

The production capacity for triacetonamine (TAA) derivatives in Liaoyang rises by 50 percent. Source: Evonik.

With the expansion, the joint venture of Evonik China and the Chinese NEPC (Northeast No.1 Electric Power Construction CO., Ltd.) is responding to continuous growth in market demand. "With our new production capacities, we can support the growth of our customers and serve global markets even more effectively,” says Zhong Yao, managing director of ETL. The construction work for the expansion began in 2017 and was successfully completed in March 2018.

Continuous growth expected

"We have been a successful player in the global TAA derivatives market for over 30 years,” says Thomas Wildt, head of the Agrochemicals & Polymer Additives Business Line. "The investment in the Liaoyang site further solidifies our leading position in TAA derivatives and consistently follows our strategy of intelligently shaping our ChemicalBusiness.” Evonik expects continuous growth in the market segment in upcoming years.
TAA derivatives are essential precursors for the manufacture of hindered amine light stabilizers (HALS). The additives are used in low concentrations to protect and stabilize polymers against decomposition caused by light, oxygen and heat and can therefore increase the life expectancy of plastic materials up to ten times. They are found in many products of the automotive and construction industry as well as in the manufacture of agricultural films.

top of page
Comments (0)
Add Comment

Post comment

You are not logged in

register